PROBAR LLC of Salt Lake City, UT has initiated a voluntary recall of its PROBAR Base Frosted Peanut Butter Bars due to the possible presence of an undeclared milk allergen. People who have an allergy or severe sensitivity to milk run the risk of a serious allergic reaction if they consume this product. No other PROBAR products are affected.
FDA approves first generic esomeprazole
The U.S. Food and Drug Administration today approved the first generic version of Nexium (esomeprazole magnesium delayed-release capsules) to treat gastroesophageal reflux disease (GERD) in adults and children ages 1 and older. Esomeprazole is a proton pump inhibitor that reduces the amount of acid in the stomach.
Comunicado Actualizado: Quesería Bendita LLC Retira Quesos Frescos Y Crema Agria Debido a Posibles Riesgos Para la Salud
Quesería Bendita LLC, de Yakima, Washington, está retirando todos los lotes de productos de queso panela, queso fresco, requesón, queso Cotija y crema agria que incluyen TODAS las fechas de caducidad debido a la posibilidad de que estén contaminados con la bacteria Listeria monocytogenes, un organismo que puede causar infecciones graves y a veces hasta mortales en infantes, personas mayores o con una salud delicada y otras personas con un sistema inmunológico debilitado. Aunque las personas sanas quizás sólo sufran síntomas a corto plazo, tales como fiebre alta, dolor de cabeza intenso, rigidez, náuseas, dolor abdominal y diarrea, la infección por listeria puede causar abortos y mortinatos (nacimiento muerto del bebé) entre las mujeres embarazadas.
Dr. Robert Califf named FDA Deputy Commissioner for Medical Products and Tobacco
U.S. Food and Drug Administration Commissioner Margaret A. Hamburg, M.D., today appointed Robert Califf, M.D., a recognized global leader in cardiology, clinical research, and medical economics, as FDA Deputy Commissioner for Medical Products and Tobacco.
Korean Food Co. Issues Allergy Alert on Undeclared Shrimp in Mak Kimchi
Korean Food Co. in Irving, Texas is recalling Mak kimchi in 32oz and half gallon glass jars, because it may contain undeclared shellfish (shrimp). People who have an allergy or severe sensitivity to shellfish (shrimp) run the risk of serious or life-threatening allergic reaction if they consume these products.
FDA approves Natpara to control low blood calcium levels in patients with hypoparathyroidism
The U.S. Food and Drug Administration today approved Natpara (parathyroid horomone) to control hypocalcemia (low blood calcium levels) in patients with hypoparathyroidism, a rare disease that affects approximately 60,000 people in the United States.
J.J. Fuds, Inc. Issues Recall of Pet Food Because of Possible Health Risk
J.J. Fuds in Valparaiso, IN is recalling a select lot and product of J.J. Fuds Chicken Tender Chunks Pet Food because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women.
Cox Veterinary Laboratory, Inc. Issues Voluntary Recall of “Gastroade Xtra”
Cox Veterinary Laboratory, Inc. is
voluntarily recalling the lots of Gastroade Xtra identified below down to the consumer level
distributed nationwide. Gastroade Xtra was previously marketed by Cox Veterinary Laboratory as
an OTC drug for use in horses, and contains Omeprazole.
FDA approves a second vaccine to prevent serogroup B meningococcal disease
The U.S. Food and Drug Administration today approved Bexsero, a vaccine to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age.
FDA permits marketing of first system of mobile medical apps for continuous glucose monitoring
The U.S. Food and Drug Administration today allowed marketing of the first set of mobile medical apps that allow people with diabetes to automatically and securely share data from a continuous glucose monitor (CGM) with other people in real-time using an Apple mobile device such as an iPhone.